Sort
85,873 grants matching “alzheimers”
Inflammasome and Gasdermin Signaling Networks for Regulation of Pyroptosis and Cytokine Release
$1,886,706George R Dubyak · Case Western Reserve University · P01 · FY2022 · AI
Inflammasome and Gasdermin Signaling Networks for Regulation of Pyroptosis and Cytokine Release
$1,886,706George R Dubyak · Case Western Reserve University · P01 · FY2023 · AI
Inflammasome and Gasdermin Signaling Networks for Regulation of Pyroptosis and Cytokine Release
$1,886,706George R Dubyak · Case Western Reserve University · P01 · FY2021 · AI
Inflammasome and Gasdermin Signaling Networks for Regulation of Pyroptosis and Cytokine Release
$1,886,706George R Dubyak · Case Western Reserve University · P01 · FY2020 · AI
Inflammasome and Gasdermin Signaling Networks for Regulation of Pyroptosis and Cytokine Release
$1,886,706George R Dubyak · Case Western Reserve University · P01 · FY2024 · AI
Leveraging the 24-hour movement paradigm to preserve cognitive function and prevent Alzheimer's disease: The Multi-Ethnic Study of Atherosclerosis (MESA) 24H-ACT Study
$1,886,663Keith M Diaz · Columbia University Health Sciences · R01 · FY2023 · AG
Clinical Evaluation of PET Radiotracers
$1,886,245Robert Innis · National Institute Of Mental Health · Z01 · FY2007 · MH
Johns Hopkins Alzheimer's Disease Research Center
$1,886,081Marilyn S Albert · Johns Hopkins University · P50 · FY2011 · AG
Infrastructure to improve reliability of AMP-AD target hypotheses
$1,885,852Lara M Mangravite · Sage Bionetworks · RF1 · FY2018 · AG
Oligodendrocyte heterogeneity in Alzheimer' s disease
$1,885,720Vivek Swarup · University Of California-Irvine · RF1 · FY2021 · AG
Novel Mechanisms of APP-Go signaling in the control of neuronal motility
$1,885,550Philip F Copenhaver · Oregon Health & Science University · RF1 · FY2020 · NS
ApoE Receptor Biology and Neurodegeneration
$1,885,220Mary Jo Ladu · University Of Illinois At Chicago · P01 · FY2012 · AG
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network
$1,884,695Michelle M Mielke · Wake Forest University Health Sciences · U24 · FY2023 · AG
HDL Mimetic Peptide-Mediated Enhancement of Neurovascular Function to Mitigate Cerebral Amyloid Angiopathy and Alzheimer's Disease
$1,884,326Ling Li · University Of Minnesota · RF1 · FY2018 · AG
Alzheimer's Disease Core Center
$1,883,508Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2015 · AG
ALZHEIMER'S DISEASE RESEARCH CENTER
$1,883,117Duke University · P50 · FY2000 · AG
Alzheimer's Disease Core Center
$1,881,451Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2019 · AG
Rush Alzheimer's Disease Core Center
$1,881,224Rush University Medical Center · P30 · FY2005 · AG
Johns Hopkins Alzheimer's Disease Research Center
$1,881,193Marilyn S Albert · Johns Hopkins University · P50 · FY2015 · AG
ALZHEIMER'S DISEASE AND ANIMAL MODELS
$1,881,052Johns Hopkins University · P50 · FY2003 · AG
Metabolic Control Analysis
$1,880,750Richard L Veech · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2017 · AA
Proteostasis in the aging and Alzheimer's disease brain: are the ATases novel targets?
$1,880,700Luigi Puglielli · University Of Wisconsin-Madison · RF1 · FY2016 · AG
Changing the Trajectory of Mild Cognitive Impairment with CPAP Treatment of Obstructive Sleep Apnea
$1,879,552Nalaka S Gooneratne · University Of Pennsylvania · R01 · FY2020 · AG
AGING BRAIN: VASCULATURE, ISCHEMIA, AND BEHAVIOR
$1,878,945University Of Southern California · P01 · FY2000 · AG
Genetic characterization of atypical parkinsonism
$1,878,852Sonja Scholz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS